These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
853 related articles for article (PubMed ID: 28884871)
1. LncRNA-ATB: An indispensable cancer-related long noncoding RNA. Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28884871 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma. Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634 [TBL] [Abstract][Full Text] [Related]
3. PANDAR: a pivotal cancer-related long non-coding RNA in human cancers. Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X Mol Biosyst; 2017 Oct; 13(11):2195-2201. PubMed ID: 28976505 [TBL] [Abstract][Full Text] [Related]
4. High expression of long non-coding RNA lncRNA-ATB is correlated with metastases and promotes cell migration and invasion in renal cell carcinoma. Xiong J; Liu Y; Jiang L; Zeng Y; Tang W Jpn J Clin Oncol; 2016 Apr; 46(4):378-84. PubMed ID: 26848077 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ATB promotes human non-small cell lung cancer proliferation and metastasis by suppressing miR-141-3p. Lu G; Zhang Y PLoS One; 2020; 15(2):e0229118. PubMed ID: 32092085 [TBL] [Abstract][Full Text] [Related]
6. The Function and Mechanism of Long Non-coding RNA-ATB in Cancers. Xiao H; Zhang F; Zou Y; Li J; Liu Y; Huang W Front Physiol; 2018; 9():321. PubMed ID: 29692736 [TBL] [Abstract][Full Text] [Related]
7. ZEB1-AS1: A crucial cancer-related long non-coding RNA. Li J; Li Z; Leng K; Xu Y; Ji D; Huang L; Cui Y; Jiang X Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29226522 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA-ATB promotes EMT during silica-induced pulmonary fibrosis by competitively binding miR-200c. Liu Y; Li Y; Xu Q; Yao W; Wu Q; Yuan J; Yan W; Xu T; Ji X; Ni C Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):420-431. PubMed ID: 29113749 [TBL] [Abstract][Full Text] [Related]
9. The function of LncRNA-ATB in cancer. Anbiyaiee A; Ramazii M; Bajestani SS; Meybodi SM; Keivan M; Khoshnam SE; Farzaneh M Clin Transl Oncol; 2023 Jan; 25(1):1-9. PubMed ID: 35597865 [TBL] [Abstract][Full Text] [Related]
10. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA activated by transforming growth factor-β promotes proliferation and invasion of cervical cancer cells by regulating the miR-144/ITGA6 axis. Zhu Y; Wu Y; Yang L; Dou X; Jiang J; Wang L Exp Physiol; 2019 Jun; 104(6):837-844. PubMed ID: 30908730 [TBL] [Abstract][Full Text] [Related]
12. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945 [TBL] [Abstract][Full Text] [Related]
13. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers. Hu Q; Tai S; Wang J Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding PANDAR as a novel biomarker in human cancer: A systematic review. Zou Y; Zhong Y; Wu J; Xiao H; Zhang X; Liao X; Li J; Mao X; Liu Y; Zhang F Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29226461 [TBL] [Abstract][Full Text] [Related]
15. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Wang J; Su Z; Lu S; Fu W; Liu Z; Jiang X; Tai S Clin Chim Acta; 2018 Oct; 485():229-233. PubMed ID: 29981289 [TBL] [Abstract][Full Text] [Related]
16. LncRNA-DANCR: A valuable cancer related long non-coding RNA for human cancers. Thin KZ; Liu X; Feng X; Raveendran S; Tu JC Pathol Res Pract; 2018 Jun; 214(6):801-805. PubMed ID: 29728310 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Xue M; Pang H; Li X; Li H; Pan J; Chen W Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536 [TBL] [Abstract][Full Text] [Related]
18. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer. Ke L; Xu SB; Wang J; Jiang XL; Xu MQ Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433 [TBL] [Abstract][Full Text] [Related]
19. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis. Yue B; Qiu S; Zhao S; Liu C; Zhang D; Yu F; Peng Z; Yan D J Gastroenterol Hepatol; 2016 Mar; 31(3):595-603. PubMed ID: 26487301 [TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV inhibits cell migration and viability of hepatocellular carcinoma cells via suppressing long noncoding RNA ATB. Li Y; Ye Y; Chen H Biomed Pharmacother; 2018 Mar; 99():134-141. PubMed ID: 29331759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]